United Therapeutics Corp Sustainability Reports

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases, specifically pulmonary arterial hypertension. It is also actively developing technologies designed to expand the availability of transplantable organs.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299005C4HZL4UWROC14

FIGI: BBG001S8RV10

11 reports from 2019 to 2025

• United Therapeutics Corp 2025 Form 10-K
• United Therapeutics Corp 2024 Form 10-K
• United Therapeutics Corp 2024 Reporting Indexes
• United Therapeutics Corp 2024 Corporate Responsibility and Public Benefit Report
• United Therapeutics Corp 2023 Form 10-K